Detalles de la búsqueda
1.
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program.
Biol Blood Marrow Transplant
; 26(8): 1386-1393, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32439475
2.
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).
Biol Blood Marrow Transplant
; 24(4): 700-707, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29289757
3.
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab.
Transplant Cell Ther
; 29(5): 314-320, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36682470
4.
Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
Cancer Epidemiol Biomarkers Prev
; 27(10): 1133-1141, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262597
5.
Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma.
Leuk Lymphoma
; 46(10): 1441-8, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16194889
6.
Hematologic disorders after solid organ transplantation.
Hematology Am Soc Hematol Educ Program
; 2010: 281-6, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21239807
7.
Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure.
Leuk Lymphoma
; 53(10): 2051-3, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22369501
8.
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.
Cancer Invest
; 23(1): 13-8, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15779863
Resultados
1 -
8
de 8
1
Próxima >
>>